Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,838 | 523 | 66.8% |
| Consulting Fee | $5,225 | 2 | 29.5% |
| Education | $663.26 | 30 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $5,801 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,328 | 59 | $0 (2024) |
| Esperion Therapeutics, Inc. | $858.01 | 42 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $818.86 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $800.94 | 34 | $0 (2024) |
| Amgen Inc. | $733.58 | 34 | $0 (2024) |
| Vifor Pharma, Inc. | $662.06 | 34 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $633.41 | 30 | $0 (2024) |
| Amarin Pharma Inc. | $632.77 | 34 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $624.79 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,105 | 122 | CALLIDITAS THERAPEUTICS US INC. ($5,367) |
| 2023 | $2,359 | 104 | AstraZeneca Pharmaceuticals LP ($360.62) |
| 2022 | $2,030 | 91 | AstraZeneca Pharmaceuticals LP ($297.94) |
| 2021 | $1,703 | 80 | GlaxoSmithKline, LLC. ($336.37) |
| 2020 | $678.32 | 36 | Amarin Pharma Inc. ($104.90) |
| 2019 | $1,489 | 52 | OPKO Pharmaceuticals, LLC ($211.77) |
| 2018 | $660.24 | 32 | Keryx Biopharmaceuticals, Inc. ($179.44) |
| 2017 | $702.15 | 38 | Amarin Pharma Inc. ($170.43) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.09 | General |
| 12/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $118.42 | General |
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $21.51 | General |
| 12/02/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.09 | General |
| Category: NEPHROLOGY | ||||||
| 11/28/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/28/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/28/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/27/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Nephrology | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/21/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.74 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: UROLOGY | ||||||
| 11/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Nephrology | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEPHROLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Hyperkalemia | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.48 | General |
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 210 | 525 | $209,796 | $71,590 |
| 2022 | 13 | 276 | 664 | $248,598 | $99,930 |
| 2021 | 14 | 421 | 2,409 | $255,178 | $138,667 |
| 2020 | 18 | 665 | 2,648 | $300,522 | $140,709 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 25 | 160 | $144,000 | $50,828 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 94 | $21,620 | $7,477 | 34.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 14 | $11,200 | $3,722 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 62 | $12,400 | $3,119 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,000 | $2,941 | 42.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 30 | $6,000 | $2,117 | 35.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 81 | $6,480 | $1,009 | 15.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 28 | $448.00 | $235.20 | 52.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 32 | 36 | $648.00 | $141.84 | 21.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 29 | 224 | $176,800 | $75,347 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 108 | $24,840 | $8,732 | 35.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 34 | 66 | $13,200 | $5,422 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,600 | $2,541 | 45.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 48 | $9,600 | $2,474 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 16 | $4,000 | $1,903 | 47.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 17 | 17 | $4,250 | $1,865 | 43.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 69 | $5,520 | $916.20 | 16.6% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2022 | 13 | 13 | $3,250 | $433.12 | 13.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 27 | 40 | $640.00 | $118.71 | 18.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 19 | 21 | $378.00 | $83.06 | 22.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 11 | 13 | $260.00 | $66.99 | 25.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 13 | $260.00 | $29.09 | 11.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 35 | 281 | $140,500 | $95,572 | 68.0% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 13 | 1,464 | $23,424 | $10,075 | 43.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 109 | $25,070 | $9,475 | 37.8% |
About Dr. Li Yang, MD
Dr. Li Yang, MD is a Nephrology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2011. The National Provider Identifier (NPI) number assigned to this provider is 1598035081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Li Yang, MD has received a total of $17,726 in payments from pharmaceutical and medical device companies, with $8,105 received in 2024. These payments were reported across 555 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($11,838).
As a Medicare-enrolled provider, Yang has provided services to 1,572 Medicare beneficiaries, totaling 6,246 services with total Medicare billing of $450,896. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Brooklyn, NY
- Active Since 12/30/2011
- Last Updated 05/12/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1598035081
Products in Payments
- TARPEYO (Drug) $5,801
- Veltassa (Drug) $929.22
- BENLYSTA (Biological) $779.00
- NEXLETOL (Drug) $733.01
- LOKELMA (Drug) $727.31
- JYNARQUE (Drug) $643.72
- Vascepa (Drug) $632.77
- RAYALDEE (Drug) $590.99
- FARXIGA (Drug) $538.41
- Velphoro (Drug) $473.29
- ACTHAR (Biological) $453.09
- PURIFIED CORTROPHIN GEL (Drug) $396.60
- Auryxia (Drug) $396.55
- Otezla (Drug) $379.13
- JARDIANCE (Drug) $367.22
- KRYSTEXXA (Biological) $300.78
- Kerendia (Drug) $284.93
- Rayaldee (Drug) $227.87
- AURYXIA (Drug) $207.56
- Uloric (Drug) $140.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Brooklyn
Gregg Miller, Md, MD
Nephrology — Payments: $57,485
Alla Maslova
Nephrology — Payments: $18,516
Dr. Louis Carrera, Md, MD
Nephrology — Payments: $17,135
Dr. Mariana Markell, M.d, M.D
Nephrology — Payments: $15,506
Dr. Alan Nissenbaum, Md, MD
Nephrology — Payments: $15,228
Dr. Lutfi Alasadi, M.d, M.D
Nephrology — Payments: $5,296